Zobrazeno 1 - 10
of 187
pro vyhledávání: '"Robert C. Owens"'
Publikováno v:
Clinical Infectious Diseases, 2005 Dec . 41(12), 1828-1828.
Externí odkaz:
https://www.jstor.org/stable/4463683
Autor:
Calvin M. Kunin
Publikováno v:
New England Journal of Medicine. 360:550-551
Autor:
David R. Snydman, Kenneth Lawrence
Publikováno v:
New England Journal of Medicine. 352:1830-1831
Autor:
Keith A. Rodvold, Gary P. Wormser
Publikováno v:
Clinical Infectious Diseases. 41:1828-1828
Autor:
Sujata M. Bhavnani, Catharine C. Bulik, Elizabeth A Lakota, Robert C. Owens, Paul G. Ambrose, Christopher M. Rubino, Kim L Sweeney, Justin C Bader
Publikováno v:
Open Forum Infectious Diseases
Background The importance of delivering appropriate therapy to patients at the onset of treatment is well established. However, this goal is easier said than done given the complexity and uniqueness of each patient case. Nonetheless, treatment decisi
Publikováno v:
Pharmacotherapy. 29:593-607
In 2007, the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America published a document that addressed the major considerations for the justification, description, and conduct of antimicrobial stewardship progr
Autor:
Robert C. Owens
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 61:110-128
Large worldwide surveillance studies report that resistance to nearly all classes of antimicrobial is increasing, as is the emergence of what have been termed pan-drug-resistant and extremely drug-resistant pathogens. Concomitantly, bacterial binding
Publikováno v:
Clinical Infectious Diseases. 46:S19-S31
Antimicrobial therapy plays a central role in the pathogenesis of Clostridium difficile infection (CDI), presumably through disruption of indigenous intestinal microflora, thereby allowing C. difficile to grow and produce toxin. Investigations involv
Concepts, Principles, and Rationale for Optimizing the Institutional Use of Antimicrobial Agents How to Create a Therapeutics Committee That is Scientifically and Economically Sound Richard Quintiliani and Robert Quercia The Public Health Action Plan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32b5963d8e24d011b21f6330fc9f1e7d
https://doi.org/10.3109/9780203996928
https://doi.org/10.3109/9780203996928
Publikováno v:
The American Journal of Medicine. 120:S6-S12
A registry describing daptomycin's clinical use was analyzed to describe treatment of skin and skin-structure infections (SSSIs). The Cubicin Outcomes Registry and Experience (CORE) 2004 retrospectively collected demographic, microbiologic, and clini